Core Viewpoint - The Hong Kong internet healthcare stocks continue to decline, with Ark Health (06086.HK) experiencing the largest drop of 18.75% as of the report date [1] Company Summary - Ark Health plans to conduct a share placement of 45.181 million shares, representing approximately 3.26% of the expanded issued share capital, at a price of HKD 3.32 per share, which is an 11.94% discount to the previous closing price [2] - The total funds raised from this placement are expected to be HKD 150 million, with a net amount of approximately HKD 144 million [2] - Approximately 90% of the funds will be allocated to the development of an AI-driven chronic disease management platform, including algorithm model development, infrastructure expansion, talent acquisition, data collection, and service promotion [4] - The remaining 10% will be used for working capital and general corporate purposes [4] Industry Summary - Ark Health's strong profit forecast for 2025 indicates expected revenue of RMB 3.5 to 3.55 billion, representing a year-on-year growth of about 30%, with net profit projected between RMB 7 million and 10 million [8] - The growth in 2025 is attributed to the integration of the "familiar doctor-patient relationship" model with AI technology, enhancing platform attractiveness and expanding the consumer base [8] - The Chinese internet healthcare market is projected to grow significantly, with the market size increasing from RMB 43.6 billion in 2016 to RMB 435.1 billion in 2024, reflecting a compound annual growth rate of 33.32% [9] - The demand for convenient medical services is driven by an aging population and chronic disease patients, alongside the uneven distribution of medical resources, which forms the underlying motivation for industry growth [8]
首次全面盈利难抵配股压力 方舟健客大跌近19%